Interestingly, the authors of this study reported that FOLFOX triggers tumor adaptive immune resistance based on increased expression of PD-1 in TILs and PDL-1 in tumor cells, suggesting that the blockade of PD-1 breaks this resistance. The gene discussed is CD274; the disease is neoplasm.